164 related articles for article (PubMed ID: 38437824)
1. Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study.
Kim MS; Lee JW; Hyun MK; Song YS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):288-299. PubMed ID: 38437824
[TBL] [Abstract][Full Text] [Related]
2. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
Shin DW; Suh B; Lim H; Yun JM; Song SO; Park Y
J Bone Miner Res; 2018 Jun; 33(6):1037-1043. PubMed ID: 29447437
[TBL] [Abstract][Full Text] [Related]
3. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract][Full Text] [Related]
4. Increased cardiovascular risk in thyroid cancer patients taking levothyroxine: a nationwide cohort study in Korea.
Suh B; Shin DW; Park Y; Lim H; Yun JM; Song SO; Park JH; Cho B; Guallar E
Eur J Endocrinol; 2019 Jan; 180(1):11-20. PubMed ID: 30400044
[TBL] [Abstract][Full Text] [Related]
5. Increased Risk of Type 2 Diabetes in Patients With Thyroid Cancer After Thyroidectomy: A Nationwide Cohort Study.
Roh E; Noh E; Hwang SY; Kim JA; Song E; Park M; Choi KM; Baik SH; Cho GJ; Yoo HJ
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1047-e1056. PubMed ID: 34718625
[TBL] [Abstract][Full Text] [Related]
6. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
7. Prediagnosis obesity and secondary primary cancer risk in female cancer survivors: A national cohort study.
Jung SY; Kim YA; Jo M; Park SM; Won YJ; Ghang H; Kong SY; Jung KW; Lee ES
Cancer Med; 2019 Feb; 8(2):824-838. PubMed ID: 30652416
[TBL] [Abstract][Full Text] [Related]
8. Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study.
Lin SY; Lin CL; Chen HT; Kao CH
Curr Med Res Opin; 2018 May; 34(5):805-812. PubMed ID: 28884595
[TBL] [Abstract][Full Text] [Related]
9. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
[TBL] [Abstract][Full Text] [Related]
10. Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-based Study.
Seo GH; Kong KA; Kim BS; Kang SY; Moon BS; Yoon HJ; Kim HO
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2580-e2588. PubMed ID: 33755732
[TBL] [Abstract][Full Text] [Related]
11. Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States.
Sung H; Hyun N; Leach CR; Yabroff KR; Jemal A
JAMA; 2020 Dec; 324(24):2521-2535. PubMed ID: 33351041
[TBL] [Abstract][Full Text] [Related]
12. Prediagnosis Body Mass Index and Risk of Secondary Primary Cancer in Male Cancer Survivors: A Large Cohort Study.
Park SM; Yun YH; Kim YA; Jo M; Won YJ; Back JH; Lee ES
J Clin Oncol; 2016 Dec; 34(34):4116-4124. PubMed ID: 27863195
[TBL] [Abstract][Full Text] [Related]
13. Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer.
Klubo-Gwiezdzinska J; Auh S; Gershengorn M; Daley B; Bikas A; Burman K; Wartofsky L; Urken M; Dewey E; Smallridge R; Chindris AM; Kebebew E
JAMA Netw Open; 2019 Feb; 2(2):e187754. PubMed ID: 30707227
[TBL] [Abstract][Full Text] [Related]
14. Risk of All-Cause Mortality in Levothyroxine-Treated Hypothyroid Patients: A Nationwide Korean Cohort Study.
Sohn SY; Seo GH; Chung JH
Front Endocrinol (Lausanne); 2021; 12():680647. PubMed ID: 34054737
[TBL] [Abstract][Full Text] [Related]
15. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
[TBL] [Abstract][Full Text] [Related]
16. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
Feller A; Matthes KL; Bordoni A; Bouchardy C; Bulliard JL; Herrmann C; Konzelmann I; Maspoli M; Mousavi M; Rohrmann S; Staehelin K; Arndt V;
BMC Cancer; 2020 Jan; 20(1):51. PubMed ID: 31964352
[TBL] [Abstract][Full Text] [Related]
17. Surgical Risk Prediction for Nasolacrimal Duct Obstruction in Radioactive Iodine-Treated Thyroid Cancer: A Nationwide Cohort Study.
Lee JY; Woo KI
Thyroid; 2022 May; 32(5):544-551. PubMed ID: 34894720
[No Abstract] [Full Text] [Related]
18. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
Seo GH; Cho YY; Chung JH; Kim SW
Thyroid; 2015 Aug; 25(8):927-34. PubMed ID: 26133388
[TBL] [Abstract][Full Text] [Related]
19. Hyperkalemia develops in some thyroidectomized patients undergoing thyroid hormone withdrawal in preparation for radioactive iodine ablation for thyroid carcinoma.
Horie I; Ando T; Imaizumi M; Usa T; Kawakami A
Endocr Pract; 2015 May; 21(5):488-94. PubMed ID: 25667379
[TBL] [Abstract][Full Text] [Related]
20. Risk of Fractures in Thyroid Cancer Patients With Postoperative Hypoparathyroidism: A Nationwide Cohort Study in Korea.
Ahn SH; Lee YJ; Hong S; Park JW; Jeon YJ; Yoo BN; Ha YC; Bak JK; Kim HY; Lee YK
J Bone Miner Res; 2023 Sep; 38(9):1268-1277. PubMed ID: 37338940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
